All services are overseen by Patricia Arledge, MD
Clinical trials of Wegovy, Mounjaro, and Ozempic showed effectiveness, but potential side effects, including hair loss in 3-6% of patients
Worryingly however, 26.8% of patients had to discontinue the trial due to the severity of side-effects, although it must be noted that this was in part due to the lack of a run-in (A time frame where drug dosage is started from a low dosage and then escalated over time until the highest tolerable dose for the patient is reached) [40]
Tirzepatide is a GLP-1 receptor agonist too, but it is also a GIP (glucose-dependent insulinotropic polypeptide) receptor agonist
Medvi Weight Loss Pills / Oral Options In addition to injectable GLP-1 medications, the Medvi weight loss pills category may include oral medication options depending on current formulary availability and physician recommendation
For many patients, counseling sessions or simple accountability check-ins make weight loss efforts easier to follow through on, especially when combined with comprehensive med spa and wellness services that support confidence and overall well-being
